October 19, 2026
Eye Drops to Treat Cataract: Clinical Trial News
According to a new announcement from Lexitas Pharma Services and Ocusun, the first patient has enrolled in a pilot study of ZOC2017217, an investigational topical eye drop for age-related cataract.¹ Enrollment took place at North Bay Eye Associates in Petaluma, California, under investigator Jason Bacharach, MD.¹ The pilot is designed to inform an upcoming pivotal Phase 3 program.¹ ..."Cataracts remain one of the leading causes of vision impairment worldwide, and the development of a potential non-surgical treatment represents an exciting opportunity to advance patient care," said Jeanne Hecht, Chief Executive Officer of Lexitas Pharma Services, in the release. "We are proud to support Ocusun in generating the clinical evidence needed to assess the potential of this innovative therapy and help inform the program's continued development."
